- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: AC2993 (exenatide)
Total 362 results
-
AstraZenecaCompletedDiabetes MellitusUnited States, Hungary, Slovakia, South Africa, Poland, Romania
-
AstraZenecaEli Lilly and CompanyCompletedObesityUnited States, Puerto Rico
-
Newron Pharmaceuticals SPAUnknown
-
Mayo ClinicCompletedPre DiabetesUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaEli Lilly and CompanyCompletedType 2 DiabetesUnited States, Mexico, United Kingdom, Israel, Puerto Rico, Greece
-
Eli Lilly and CompanyCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States, United Kingdom
-
University College, LondonUnknownMultiple System AtrophyUnited Kingdom
-
Beth Israel Deaconess Medical CenterEli Lilly and Company; Amylin Pharmaceuticals, LLC.CompletedObesity | Impaired Glucose ToleranceUnited States
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusItaly
-
AstraZenecaEli Lilly and CompanyCompleted
-
AstraZenecaEli Lilly and CompanyCompleted
-
Dong-A Pharmaceutical Co., Ltd.CompletedDiabetes MellitusKorea, Republic of
-
Peptron, Inc.CompletedType 2 Diabetes MellitusKorea, Republic of
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Poland, Puerto Rico, Denmark, Sweden, Austria, Germany, Macedonia, The Former Yugoslav Republic of, Slovenia, France, Switzerland, Norway, Spain, Ireland, Finland, Romania
-
University Hospital, CaenEli Lilly and CompanyUnknown
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaEli Lilly and CompanyCompleted
-
Neuroscience Trials AustraliaNational Health and Medical Research Council, Australia; Monash UniversityActive, not recruitingAcute Ischemic StrokeAustralia, Finland, New Zealand
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusKorea, Republic of, China, Taiwan, India
-
University of AarhusEli Lilly and Company; Aarhus University HospitalCompleted
-
AstraZenecaCompletedComparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal InsulinsType 2 DiabetesUnited States
-
University College, LondonActive, not recruitingParkinson's DiseaseUnited Kingdom
-
AstraZenecaWithdrawn
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
AstraZenecaCompletedType 2 DiabetesUnited States
-
University of Alabama at BirminghamAmylin Pharmaceuticals, LLC.TerminatedType 2 Diabetes Mellitus | Bone RemodelingUnited States
-
University at BuffaloAstraZenecaCompletedEvaluate Ketogenic StressUnited States
-
Huazhong University of Science and TechnologyCompletedType 2 Diabetes MellitusChina
-
AstraZenecaEli Lilly and CompanyCompleted
-
Beijing Chao Yang HospitalCompleted
-
Kyunghee University Medical CenterCompleted
-
Amsterdam UMC, location VUmcUnknownPatients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).Netherlands
-
AstraZenecaCompletedChildren and Adolescent With Type 2 DiabetesUnited States, Hungary, Israel, Mexico, Bulgaria, Ukraine, Kuwait
-
TheracosCompletedType2 Diabetes MellitusUnited States
-
PegBio Co., Ltd.Completed
-
Accutar Biotechnology IncRecruiting
-
Chinese University of Hong KongRecruitingCerebral Small Vessel DiseaseHong Kong
-
Yale UniversityCompleted
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Austria, Canada, Italy, Netherlands, Spain, United Kingdom, Taiwan, Thailand, Bulgaria, Belgium, Germany, Korea, Republic of, Hungary, Philippines, China, Malaysia, Hong Kong, New Zealand, Argentina, Czechia, Slovakia, Braz... and more
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States
-
Intarcia TherapeuticsCompleted
-
Merck Sharp & Dohme LLCCompletedThe Methodology Assessment of Glucose Dependent Insulin Secretion
-
National Institute of Diabetes and Digestive and...CompletedObesity | Weight LossUnited States
-
Phoenix VA Health Care SystemUnknownType 2 DiabetesUnited States
-
University of DundeeNewcastle-upon-Tyne Hospitals NHS Trust; Oxford University Hospitals NHS Trust and other collaboratorsCompletedDiabetesUnited Kingdom
-
Jesper KjaergaardCompleted
-
Intarcia TherapeuticsCompletedRenal InsufficiencyGermany, United States